EICHORCondition: Hypercholesterolemia · Familial Hypercholesterolemia · Sponsor: Merck Sharp & Dohme LLC
The goal of this study is to evaluate the efficacy, safety, and tolerability of enlicitide decanoate in adult participants with hypercholesterolemia. The primary hypothesis is that enlicitide decanoate is superior to placebo on mean percent change from baseline in low-density lipoprotein cholesterol (LDL-C) at Week 24.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Alliance for Multispecialty Research, LLC ( Site 0093) | Daphne, Alabama, United States | — |
| G&L Research ( Site 0043) | Foley, Alabama, United States | — |
| Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0084) | Phoenix, Arizona, United States | — |
| National Heart Institute-Research ( Site 0087) | Beverly Hills, California, United States | — |
| Clinical Trials Research ( Site 0115) | Sacramento, California, United States | — |
| Velocity Clinical Research, Banning ( Site 0017) | San Bernardino, California, United States | — |
| Emerson Clinical Research Institute ( Site 0118) | Washington D.C., District of Columbia, United States | — |
| Excel Medical Clinical Trials ( Site 0053) | Boca Raton, Florida, United States | — |
| Alliance for Multispecialty Research, LLC ( Site 0088) | Coral Gables, Florida, United States | — |
| Alliance for Multispecialty Research, LLC ( Site 0094) | Fort Myers, Florida, United States | — |
| Velocity Clinical Research, Hallandale Beach ( Site 0018) | Hallandale, Florida, United States | — |
| Jacksonville Center for Clinical Research ( Site 0049) | Jacksonville, Florida, United States | — |
+ 156 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05952856